Leslie S. Wolfe, Ph.D. 

Site Head & VP, Process Development – Venture Center, NC, United States 

Leslie Wolfe joined KBI Biopharma in March 2012 after completing her Ph.D. at Yale University in Molecular Biophysics and Biochemistry. She has experience with 50+ biotherapeutics in the clinical and pre-commercial launch phase of development, including mAbs, Fc-fusions, biosimilars, vaccine glycoproteins, enzymes and novel recombinant proteins; and has several works published in highly respected scientific journals. Leslie is skilled at building high functioning, cross functional teams to support complex programs and workflows, and has demonstrated exceptional leadership abilities and an unwavering commitment to the success of our customer programs. In addition to Site Head, Leslie will continue as Vice President, Process Development supporting the global KBI mammalian network. 
 
Prior to earning her Ph.D. in Molecular Biophysics and Biochemistry at Yale University, Leslie obtained her B.S. in Biology at Wake Forest University.